Back
Molecular Partners AG Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
21
MOLN
Molecular Partners AG
Last Price:
5.34
Seasonality Move:
28.54%
Sell
24
NLSP
NLS Pharmaceutics
Last Price:
3.39
Seasonality Move:
34.69%
Sell
21
Molecular Partners AG (MOLN)
is a Sell
Is Molecular Partners AG a Buy, Sell or Hold?
- The current Molecular Partners AG [MOLN] share price is $5.20. The Score for MOLN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- MOLN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.29. The Score for NLSP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MOLN Stock Price Chart
What is Molecular Partners AG's stock price today?
-
The Molecular Partners AG share price today is $5.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MOLN is experiencing buying pressure, which is a positive indicator for future bullish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight buying pressure.
MOLN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 44.42 | Sell |
Chaikin Money Flow: | -27389 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 35.49 | Sell |
Chaikin Money Flow: | -12070 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MOLN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.51 | Sell |
20-day SMA: | 5.85 | Sell |
50-day SMA: | 5.37 | Sell |
200-day SMA: | 5.18 | Buy |
8-day EMA: | 5.53 | Sell |
20-day EMA: | 5.64 | Sell |
50-day EMA: | 5.62 | Sell |
200-day EMA: | 5.44 | Sell |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.45 | Sell |
20-day SMA: | 3.8 | Sell |
50-day SMA: | 4.59 | Sell |
200-day SMA: | 7.43 | Sell |
8-day EMA: | 3.43 | Sell |
20-day EMA: | 3.81 | Sell |
50-day EMA: | 4.56 | Sell |
200-day EMA: | 9.37 | Sell |
Molecular Partners AG Earnings Growth & MOLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.08 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Molecular Partners AG Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |